Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Global Blood Ther (GBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,089,261
  • Shares Outstanding, K 56,322
  • Annual Sales, $ 0 K
  • Annual Income, $ -174,190 K
  • 60-Month Beta 2.12
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.94
  • Number of Estimates 11
  • High Estimate -0.74
  • Low Estimate -1.02
  • Prior Year -0.87
  • Growth Rate Est. (year over year) -8.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.56 +12.95%
on 03/25/19
59.95 -8.51%
on 04/12/19
+1.96 (+3.71%)
since 03/18/19
3-Month
43.69 +25.54%
on 01/29/19
59.95 -8.51%
on 04/12/19
+5.98 (+12.24%)
since 01/18/19
52-Week
30.15 +81.92%
on 11/30/18
59.95 -8.51%
on 04/12/19
+9.20 (+20.15%)
since 04/18/18

Most Recent Stories

More News
Global Blood The Shares Up 26.6% Since SmarTrend's Buy Recommendation (GBT)

SmarTrend identified an Uptrend for Global Blood The (NASDAQ:GBT) on January 11th, 2019 at $45.36. In approximately 3 months, Global Blood The has returned 26.63% as of today's recent price of $57.44....

GBT : 54.85 (-3.07%)
Look for Shares of Global Blood The to Potentially Rebound after Yesterday's 3.49% Sell Off

Global Blood The (NASDAQ:GBT) traded in a range yesterday that spanned from a low of $56.77 to a high of $59.19. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $57.63...

GBT : 54.85 (-3.07%)
Global Blood The Shares Up 30.1% Since SmarTrend's Buy Recommendation (GBT)

SmarTrend identified an Uptrend for Global Blood The (NASDAQ:GBT) on January 11th, 2019 at $45.36. In approximately 3 months, Global Blood The has returned 30.09% as of today's recent price of $59.01....

GBT : 54.85 (-3.07%)
GBT Announces New Employment Inducement Grants

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on April 1, 2019, the compensation committee of GBT's board of directors granted 10 new employees restricted stock units representing...

GBT : 54.85 (-3.07%)
GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the H.C. Wainwright Global Life Sciences Conference in London on Tuesday, April 9, 2019, at 10:10 a.m. British...

GBT : 54.85 (-3.07%)
Global Blood The Set to Possibly Pullback After Yesterday's Rally of 1.65%

Global Blood The (NASDAQ:GBT) traded in a range yesterday that spanned from a low of $52.17 to a high of $53.83. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of...

GBT : 54.85 (-3.07%)
Global Blood (GBT) Down 1% Since Last Earnings Report: Can It Rebound?

Global Blood (GBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GBT : 54.85 (-3.07%)
Global Blood Focuses on Developing Lead Candidate Voxelotor

Global Blood (GBT) is fast progressing on the development plans for its lead pipeline candidate, voxelotor for the treatment of sickle cell disease.

BLUE : 137.06 (-1.67%)
GBT : 54.85 (-3.07%)
NVS : 76.41 (-1.15%)
PFE : 39.38 (-1.25%)
GBT Announces New Employment Inducement Grants

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on March 1, 2019, the compensation committee of GBT's board of directors granted 10 new employees options to purchase an aggregate...

GBT : 54.85 (-3.07%)
Detailed Research: Economic Perspectives on Intelsat S.A, Sprint, Restaurant Brands International, Tower Semiconductor, TE Connectivity, and Global Blood Therapeutics -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Intelsat S.A. (NYSE:I), Sprint Corporation...

TSEM : 17.67 (-1.34%)
QSR : 67.76 (+1.93%)
S : 5.77 (+2.30%)
GBT : 54.85 (-3.07%)
I : 19.50 (+1.40%)
TEL : 89.43 (+0.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade GBT with:

Business Summary

Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Its product candidate consists of GBT440 is an oral, once-daily prophylactic therapy for sickle cell disease which...

See More

Key Turning Points

2nd Resistance Point 59.24
1st Resistance Point 57.04
Last Price 54.85
1st Support Level 52.60
2nd Support Level 50.36

See More

52-Week High 59.95
Last Price 54.85
Fibonacci 61.8% 48.57
Fibonacci 50% 45.05
Fibonacci 38.2% 41.53
52-Week Low 30.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar